MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1074/mcp.m114.046540

Медицинская библиотека · Molecular & cellular proteomics : MCP · 2015

Discovery and targeted proteomics on cutaneous biopsies infected by borrelia to investigate lyme disease.

Schnell Gilles, Boeuf Amandine, Westermann Benoît, Jaulhac Benoît, Lipsker Dan, Carapito Christine, Boulanger Nathalie, Ehret-Sabatier Laurence

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Lyme disease is the most important vector-borne disease in the Northern hemisphere and represents a major public health challenge with insufficient means of reliable diagnosis. Skin is rarely investigated in proteomics but constitutes in the case of Lyme disease the key interface where the pathogens can enter, persist, and multiply. Therefore, we investigated proteomics on skin samples to detect Borrelia proteins directly in cutaneous biopsies in a robust and specific way. We first set up a discovery gel prefractionation-LC-MS/MS approach on a murine model infected by Borrelia burgdorferi sensu stricto that allowed the identification of 25 Borrelia proteins among more than 1300 mouse proteins. Then we developed a targeted gel prefractionation-LC-selected reaction monitoring (SRM) assay to detect 9/33 Borrelia proteins/peptides in mouse skin tissue samples using heavy labeled synthetic peptides. We successfully transferred this assay from the mouse model to human skin biopsies (naturally infected by Borrelia), and we were able to detect two Borrelia proteins: OspC and flagellin. Considering the extreme variability of OspC, we developed an extended SRM assay to target a large set of variants. This assay afforded the detection of nine peptides belonging to either OspC or flagellin in human skin biopsies. We further shortened the sample preparation and showed that Borrelia is detectable in mouse and human skin biopsies by directly using a liquid digestion followed by LC-SRM analysis without any prefractionation. This study thus shows that a targeted SRM approach is a promising tool for the early direct diagnosis of Lyme disease with high sensitivity (<10 fmol of OspC/mg of human skin biopsy).

Для цитирования: Schnell Gilles, Boeuf Amandine, Westermann Benoît, Jaulhac Benoît, Lipsker Dan, Carapito Christine, Boulanger Nathalie, Ehret-Sabatier Laurence. Discovery and targeted proteomics on cutaneous biopsies infected by borrelia to investigate lyme disease.. Molecular & cellular proteomics : MCP. 2015. DOI: 10.1074/mcp.m114.046540.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.